Skip to main content
Year archive

Gentian Diagnostics ASA — 2023 filings

All 48 regulatory filings released by Gentian Diagnostics ASA (GENT) in 2023, sourced directly from the official regulator.

48 Filings
2023 Period
2023 filings (48)
Filing Released Lang
Disclosure of shareholding
Major Shareholding Notification
2023-12-19 English
Resignation of board member
Board/Management Information
2023-12-18 English
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference
Investor Presentation
2023-12-14 English
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference
Report Publication Announcement
2023-12-14 English
Financial calendar
Report Publication Announcement
2023-12-11 English
Mandatory notification of trade
Director's Dealing
2023-11-24 English
Mandatory notification of trade
Director's Dealing
2023-11-24 English
Third quarter 2023 report
Investor Presentation
2023-10-26 English
Third quarter 2023 report
Interim / Quarterly Report Q3 2023
2023-10-26 English
Third quarter 2023 report
Earnings Release Q3 2023
2023-10-26 English
Invitation to presentation of third quarter results
Report Publication Announcement
2023-10-18 English
Expanding product portfolio with turbidimetric Retinol-Binding Protein (RBP) immunoassay
Environmental & Social Information
2023-09-29 English
Expanding product portfolio with turbidimetric Retinol-Binding Protein (RBP) immunoassay
Regulatory Filings
2023-09-29 English
Mandatory notification of trade
Director's Dealing
2023-08-29 Norwegian
Mandatory notification of trade
Director's Dealing
2023-08-29 English
Second quarter 2023 report
Investor Presentation
2023-08-24 English
Second quarter 2023 report
Earnings Release Q2 2023
2023-08-24 English
Second quarter 2023 report
Earnings Release Q2 2023
2023-08-24 English
Invitation to presentation of second quarter results
Report Publication Announcement
2023-08-16 English
Gentian acquires Getica for SEK 3.0 million
M&A Activity
2023-06-15 English
Capital Markets Day at 12.30 CEST today
Investor Presentation
2023-05-10 English
Capital Markets Day at 12.30 CEST today
Report Publication Announcement
2023-05-10 English
Reminder: Invitation to Capital Markets Day 10 May 2023
Regulatory Filings
2023-05-08 English
Disclosure of shareholdings – Holta Invest AS
Director's Dealing
2023-05-05 English
Mandatory notification of trade
Director's Dealing
2023-05-05 Norwegian
Mandatory notification of trade
Director's Dealing
2023-05-05 Norwegian
Mandatory notification of trade
Director's Dealing
2023-05-05 Norwegian
Mandatory notification of trade
Director's Dealing
2023-05-05 English
First quarter 2023 report
Investor Presentation
2023-05-05 English
First quarter 2023 report
Investor Presentation
2023-05-05 English
First quarter 2023 report
Earnings Release Q1 2023
2023-05-05 English
Minutes from Annual General Meeting
AGM Information
2023-05-04 Norwegian
Minutes from Annual General Meeting
AGM Information
2023-05-04 English
Invitation to presentation of first quarter results
Report Publication Announcement
2023-04-27 English
Gentian Diagnostics invites to Capital Markets Day
Investor Presentation
2023-04-14 English
Notice of annual general meeting
AGM Information
2023-04-12 English
Notice of annual general meeting
AGM Information
2023-04-12 English
Annual report 2022
Annual Report FY 2022
2023-03-30 English
Annual report 2022
Annual Report (ESEF) FY 2022
2023-03-30 English
Annual report 2022
Report Publication Announcement
2023-03-30 English
Health economic model identifies GCAL® as a cost-effective biomarker
Regulatory Filings FY 2020
2023-03-22 English
Health economic model identifies GCAL® as a cost-effective biomarker
Report Publication Announcement
2023-03-22 English
Financial calendar
Report Publication Announcement
2023-03-17 English
Fourth quarter and full year 2022 report
Investor Presentation
2023-02-16 English
Fourth quarter and full year 2022 report
Earnings Release Q4 2022
2023-02-16 English
Fourth quarter and full year 2022 report
Earnings Release Q4 2022
2023-02-16 English
New study addresses the use of plasma calprotectin in sepsis management
Regulatory Filings
2023-02-15 English
Invitation to presentation of fourth quarter results
Report Publication Announcement
2023-02-10 English